September 4, 2024 Revolutionizing Cancer Care: Lab Genomics Expands Groundbreaking NGS Test Portfolio to Tackle US Market
September 4, 2024 Centessa Pharmaceuticals Soars to New Heights: Stock Skyrockets to 52-Week High of $14.49
